Skip to content

Alessandro Vento

7 papers in the library · 253 citations · publishing 2019-2026

Papers

Sort Most recent Most cited

Stimulant New Psychoactive Substances

New Psychoactive Substances June 1, 2026 Fabrizio Schifano, John Martin Corkery, Valeria Catalani et al.

Abstract: Given the large numbers of stimulant NPS having recently been identified from web crawler activities, this chapter comments on the pharmacological, clinical pharmacological, toxicity, and acute/chronic treatment/management issues pertaining to a range of novel stimulants, including psychedelic phenethylamines, novel amphetamine-like molecules, synthetic cathinones, synthetic cocaine...

Stimulant and hallucinogenic novel psychoactive substances; an update

Expert Review of Clinical Pharmacology November 2, 2023 Fabrizio Schifano, Alessandro Vento, Norbert Scherbaum et al. 30 citations

Clinicians should be regularly informed about the range of NPS and their medical, psychobiological and psychopathological risks both in the acute and long term. Future research should focus on an integrative model in which pro-drug websites' analyses are combined with advanced research approaches, including computational chemistry studies so that in vitro and in vivo preclinical studies of...

DOI: 10.1080/17512433.2023.2279192 (opens in new tab) MDMA Stimulant Hallucinogen Pharmacology +1

New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review.

Experimental Neurology May 1, 2021 Fabrizio Schifano, Stefania Chiappini, Andrea Miuli et al. 49 citations

The use of several new psychoactive substances (NPS) has become very popular and is posing global health risks. Chemically and pharmacologically diverse molecules are constantly emerging and are presenting with a wide range of clinical implications. Serotonin toxicity, and specifically Serotonin Syndrome (SS), might develop as a result of an over-activation of the serotoninergic system caused...

DOI: 10.1016/j.expneurol.2021.113638 (opens in new tab) Full text (opens in new tab) Bupropion New psychoactive substances Phenethylamines Serotonin syndrome +4

Psychonauts’ psychedelics: A systematic, multilingual, web-crawling exercise

European Neuropsychopharmacology April 13, 2021 Valeria Catalani, John Corkery, Amira Guirguis et al. 18 citations

Psychedelics alter the perception of reality through agonist or partial agonist interaction with the 2A serotoninergic receptor. They are classified as phenethylamines, tryptamines and lysergamides. These classes, according to the United Nations Office on Drugs and Crime (UNODC) and European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), account for an important percentage of the new...

DOI: 10.1016/j.euroneuro.2021.03.006 (opens in new tab) Phenethylamines Pergolide Crawling Hallucinogen +4

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Frontiers in Psychiatry February 9, 2021 Valeria Catalani, Davide Arillotta, John Corkery et al. 38 citations

COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of the current research were to use a web crawler, NPSfinder®, to identify and categorize emerging NPS discussed on a range of drug...

DOI: 10.3389/fpsyt.2020.632405 (opens in new tab) Addiction Social media Pandemic Illicit drug +4

The e-Psychonauts' 'Spiced' World; Assessment of the Synthetic Cannabinoids' Information Available Online.

Current Neuropharmacology 2020 Caroline Zangani, Fabrizio Schifano, Flavia Napoletano et al.

Background: A wide range of novel psychoactive substances (NPS) is regularly searched and discussed online by web-based drug enthusiasts (i.e. the e-psychonauts). Among NPS, the range of synthetic cannabinoids (SC; 'Spice') currently represents a challenge for governments and clinicians. Methods: Using a web crawler (i.e. the NPS.Finder®), the present study aimed at assessing psychonauts'...

New/emerging psychoactive substances and associated psychopathological consequences

Psychological Medicine July 22, 2019 Fabrizio Schifano, Flavia Napoletano, Stefania Chiappini et al. 118 citations

BACKGROUND: The present paper provides an updated review of both the large number of new/novel/emerging psychoactive substances (NPS) and their associated psychopathological consequences. Focus was here given on identification of those NPS being commented in specialised online sources and the related short-/long-term psychopathological and medical ill-health effects. METHODS: NPS have been...

DOI: 10.1017/s0033291719001727 (opens in new tab) Psychopathology Medical prescription Synthetic cannabinoids Mental health +2